A professional look at how pediatric HCPs identify adolescent mental-health concerns, respond to self-harm risk, choose treatment, and manage care when psychotherapy and psychiatric access are limited.
Audience: Pediatric HCPs
Countries: 5
Completion Rate: 65.2%
SGID: 9008991
-Hero findings
– Quick Read — Key Findings
Anxiety, depressive symptoms, school or social decline, self-harm concerns, family dynamics, and treatment access can all arrive in the same consultation, often before a specialist is involved.
The MDForLives survey captures how pediatric HCPs move from presentation to assessment, treatment, safety escalation and follow-up, and current AAP guidance treats screening, assessment, early intervention, referral and comanagement as integral to pediatric practice. The practical tension is that identification can happen quickly while access to psychotherapy or psychiatry may not.
38.7% identify anxiety symptoms as the presentation most likely to prompt evaluation, followed by depressive symptoms at 34.0%.
Anxiety (38.7%) and depression (34.0%) are the most common presentations, but once clinicians move to formal assessment the hierarchy shifts: a positive depression screen leads at 43.2% and suicidal thoughts or behavior at 34.9%. Pediatric guidance supports routine mental, emotional and behavioral screening and stresses that suicide-risk screening needs a defined follow-up pathway when positive.
56.9% select psychotherapy referral as their primary first-line approach for moderate symptoms.
Psychotherapy is the clear first-line preference here, consistent with guideline-based care where evidence-based psychotherapy is a core option and medication is added when clinically appropriate. The survey also shows why referral alone cannot be the whole plan: 36.1% say limited psychotherapy access most limits initial treatment success and 34.7% cite poor follow-up adherence.
79.6% say suicidal ideation or self-harm most changes their management strategy.
Suicidal ideation or self-harm changes management more than any other subgroup factor, and AAP suicide-prevention guidance recommends a structured response to a positive screen, including further safety assessment and management matched to risk. The result reinforces that self-harm risk is not just another comorbidity: it changes the pace, setting, monitoring and urgency of care.
44.8% primarily initiate or adjust medication when symptoms worsen, while 28.0% move to urgent psychiatric referral.
The pattern suggests a tiered response rather than one automatic escalation: medication management leads, but a substantial share choose urgent referral or emergency safety evaluation, depending on diagnosis, severity, functional decline, prior treatment response and immediate safety.
55.3% identify limited psychiatric access as the biggest barrier to effective adolescent mental healthcare.
Limited specialist access dominates the barriers at 55.3%, and the open responses make it concrete: long waits, unavailable therapy, distance, cost, family reluctance and poor adherence. A referral may therefore begin a period in which the pediatric clinician remains the most consistent clinical contact.
73.4% select integrated behavioral health clinics as the development most likely to transform care within the next 3–5 years.
Integrated behavioral health leads future priorities at 73.4%, and that fits the rest of the survey: clinicians favor psychotherapy, name access as the biggest barrier and describe referral fragmentation. Bringing behavioral-health capability closer to pediatric care could shorten the distance between screening, assessment, treatment, crisis response and follow-up.
The survey shows a recognisable sequence: anxiety and depressive symptoms prompt evaluation; screening and safety signals set the level of assessment; psychotherapy is preferred for moderate symptoms; worsening symptoms can require medication changes, urgent referral or emergency evaluation; and sustained improvement, rather than one completed intervention, most supports stepping follow-up down.
The friction sits between those decisions: limited psychiatric access leads the system barriers, psychotherapy access and follow-up adherence limit initial treatment success, and open cases repeatedly describe delays, family dynamics, cost, poor engagement, school difficulties and self-harm risk. So the pediatric clinician may need to stay actively involved even after a referral is placed.
The strong preference for integrated behavioral health points to a practical direction: shorten the distance between identification and treatment, make specialist input easier to reach, and build continuity into the care environment adolescents already use.
You have read the summary
Access the complete report or join MDForLives to share your perspectives in future healthcare research.
Direct answers to common clinical questions about screening, safety assessment, treatment, referral, and integrated behavioral-health care for adolescents.
Direct answers to the questions healthcare professionals are most likely to ask about these findings.
